- Lobbying
- Lobbying by Verax Biomedical
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Thomas Scully | Administrator & Consultant, CMS; Dep. Asst. to President; Counselor to the Dir., Dir. for Hum. Res. Vets and Labor; Associate Dir. for Legislative Affairs, OMB |
Colin Roskey | Health Policy Advisor and Counsel, Senate Finance Committee |
Rudy Missmar | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Type of Issue
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Type of Issue
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Type of Issue
Medicare
Registration
Issue(s) they said they’d lobby about: Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate